Boehringer Ingelheim Partners with Quallent Pharmaceuticals to Expand the Access of Cyltezo (Biosimilar, Humira)
Shots: Boehringer Ingelheim has signed an agreement with Quallent Pharmaceuticals...
Shots: Boehringer Ingelheim has signed an agreement with Quallent Pharmaceuticals...
Shots: Xbrane & STADA have signed an exclusive license agreement with Valorum...
Shots: Boehringer Ingelheim has received the US FDA’s approval for the high-...
Shots: The EMA’s CHMP has issued a positive opinion recommending appro...
Shots: The EC has granted marketing authorization for Pyzchiva (Biosimilar,&...
Shots: The US FDA has approved Selarsdi (ustekinumab-aekn) injection (SC) for adul...
Incisive News in 3 Shots.